The DOI matches its Crossref record.
Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis
Open accessAbstract
Endothelial cell production of anticoagulant heparan sulfate (HS(act)) is controlled by the Hs3st1 gene, which encodes the rate-limiting enzyme heparan sulfate 3-O-sulfotransferase-1 (3-OST-1). In vitro, HS(act) dramatically enhances the neutralization of coagulation proteases by antithrombin. The in vivo role of HS(act) was evaluated by generating Hs3st1(-/-) knockout mice. Hs3st1(-/-) animals were devoid of 3-OST-1 enzyme activity in plasma and tissue extracts. Nulls showed dramatic reductions in tissue levels of HS(act) but maintained wild-type levels of tissue fibrin accumulation under both normoxic and hypoxic conditions. Given that vascular HS(act) predominantly occurs in the subendothelial matrix, mice were subjected to a carotid artery injury assay in which ferric chloride administration induces de-endothelialization and occlusive thrombosis. Hs3st1(-/-) and Hs3st1(+/+) mice yielded indistinguishable occlusion times and comparable levels of thrombin.antithrombin complexes. Thus, Hs3st1(-/-) mice did not show an obvious procoagulant phenotype. Instead, Hs3st1(-/-) mice exhibited genetic background-specific lethality and intrauterine growth retardation, without evidence of a gross coagulopathy. Our results demonstrate that the 3-OST-1 enzyme produces the majority of tissue HS(act). Surprisingly, this bulk of HS(act) is not essential for normal hemostasis in mice. Instead, 3-OST-1-deficient mice exhibited unanticipated phenotypes suggesting that HS(act) or additional 3-OST-1-derived structures may serve alternate biologic roles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 50
- 10.1038/246355a0 · DOI · Paper page
- 10.1172/JCI119377 · DOI · Paper page
- Rosenberg, 2001, Thromb. Haemost., 86, 41, 10.1055/s-0037-1616199 · DOI
- Thomas, 1997, Ann. Intern. Med., 126, 638, 10.7326/0003-4819-126-8-199704150-00009 · DOI
- Hogan, 2002, Thromb. Haemost., 87, 563, 10.1055/s-0037-1613050 · doi:10.1055/s-0037-1613050
- van Boven, 1997, Semin. Hematol., 34, 188
- 10.1172/JCI10489 · DOI · Paper page
- Shworak, 1994, J. Biol. Chem., 269, 24941, 10.1016/S0021-9258(17)31481-3 · DOI
- Colliec-Jouault, 1994, J. Biol. Chem., 269, 24953, 10.1016/S0021-9258(17)31482-5 · DOI
- Dewerchin, 2001, Circulation., 104(Suppl. 2), 109442
- Bourin, 1990, J. Biol. Chem., 265, 15424, 10.1016/S0021-9258(18)55414-4 · doi:10.1016/s0021-9258(18)55414-4
- 10.1021/bi00383a018 · doi:10.1021/bi00383a018
- 10.1083/jcb.111.3.1293 · DOI · Paper page
- Xu, 1994, J. Histochem. Cytochem., 42, 1365, 10.1177/42.10.7930519 · doi:10.1177/42.10.7930519
- Iozzo, 2001, J. Clin. Invest., 108, 165, 10.1172/JCI200113560 · DOI
- Esko, 2001, J. Clin. Invest., 108, 169, 10.1172/JCI200113530 · doi:10.1172/jci200113530 · Paper page
- 10.1074/jbc.271.43.27063 · DOI
- 10.1074/jbc.271.43.27072 · DOI
- 10.1074/jbc.272.44.28008 · DOI · Paper page
- 10.1074/jbc.M100204200 · DOI
- 10.1074/jbc.274.8.5170 · DOI · Paper page
- 10.1074/jbc.274.8.5185 · DOI · Paper page
- 10.1016/S0092-8674(00)80058-6 · DOI · Paper page
- 10.1042/0264-6021:3590235 · DOI
- 10.1038/12447 · DOI · Paper page
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.1006/abio.1997.2494 · doi:10.1006/abio.1997.2494
- 10.1016/0006-291X(85)90615-1 · DOI · Paper page
- 10.1002/jcb.240540206 · doi:10.1002/jcb.240540206
- 10.1093/glycob/11.3.183 · DOI
- 10.1172/JCI7141 · DOI
- 10.1172/JCI2006 · DOI · Paper page
- 10.1161/hq0901.094496 · DOI
- 10.1073/pnas.96.3.915 · DOI
- 10.1016/S1074-7613(00)80103-X · DOI · Paper page
- Marcum, 1986, J. Biol. Chem., 261, 7507, 10.1016/S0021-9258(17)38421-1 · DOI · Paper page
- 10.1172/JCI111401 · DOI
- 10.1172/JCI119337 · DOI
- Konstantinides, 2001, J. Clin. Invest., 108, 1533, 10.1172/JCI13143 · DOI · Paper page
- 10.1182/blood.V98.2.368 · DOI
- He, 2002, J. Clin. Invest., 109, 213, 10.1172/JCI0213432 · doi:10.1172/jci0213432
- 10.1074/jbc.M101441200 · DOI
- 10.1006/bcmd.2000.0329 · DOI
- 10.1016/S0301-2115(00)00491-7 · DOI
- Lang, 2000, Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R53, 10.1152/ajpregu.2000.279.1.R53 · DOI
- 10.1016/S0029-7844(98)00328-7 · DOI · Paper page
- Dilmen, 1996, Fetal Diagn. Ther., 11, 50, 10.1159/000264279 · DOI
- 10.1053/plac.1999.0420 · DOI
- 10.1056/NEJM199901073400102 · DOI · Paper page
- 10.1002/dev.420110307 · DOI
Cited by
Heparan sulphate proteoglycans fine-tune mammalian physiology
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007) · Nature · doi:10.1038/nature05817 · Cited by 1,631
Sarrazin, S., Lamanna, W. C., & Esko, J. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004952 · Cited by 1,516
Taylor, K. R., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4682rev · Cited by 639
“However, HS3ST1-deficient mice are viable and exhibit no obvious procoagulant phenotype (30, 31).”
BackgroundThrombosis in paroxysmal nocturnal hemoglobinuria
Hill, A., Kelly, R. J., & Hillmen, P. (2013) · Blood · doi:10.1182/blood-2012-09-311381 · Cited by 478
Heparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410
The Molecular Diversity of Glycosaminoglycans Shapes Animal Development
Bülow, H. E., & Hobert, O. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093433 · Cited by 344
Sulfotransferases in glycosaminoglycan biosynthesis
Kusche-Gullberg, M. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.08.002 · Cited by 307
Heparan Sulfate Biosynthesis: Regulation and Variability
Kreuger, J., & Kjellén, L. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412464972 · Cited by 301
Heparan Sulfate: Biosynthesis, Structure, and Function
(2016) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.02.009 · Cited by 298
Ashikari-Hada, S., Habuchi, H., Kariya, Y., Itoh, N., Reddi, A. H., & Kimata, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313523200 · Cited by 296
Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
Heparan sulfate proteoglycans: a sugar code for vertebrate development?
Poulain, F. E., & Yost, H. J. (2015) · Development · doi:10.1242/dev.098178 · Cited by 139
Habuchi, H., Nagai, N., Sugaya, N., Atsumi, F., Stevens, R. L., & Kimata, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607434200 · Cited by 139
Shworak, N. W., HajMohammadi, S., de Agostini, A. I., & Rosenberg, R. D. (2002) · Glycoconjugate Journal · doi:10.1023/a:1025377206600 · Cited by 77
Self-citationHuman genetic disorders and knockout mice deficient in glycosaminoglycan
Mizumoto, S., Yamada, S., & Sugahara, K. (2014) · BioMed Research International · doi:10.1155/2014/495764 · Cited by 54
Metadata
- Authors
- HajMohammadi, S., Enjyoji, K., Princivalle, M., Christi, P., Lech, M., Beeler, D., Rayburn, H., Schwartz, J. J., Barzegar, S., de Agostini, A. I., Post, M. J., Rosenberg, R. D., & Shworak, N. W.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-04-01
- Volume
- 111
- Issue
- 7
- Pages
- 989-999
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2139886856
- Cited by
- 158
- References
- 0
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.